Skip to main content

Genesis Healthcare

corporate_fare Company Profile

Genesis Healthcare

GENNQ·OTC·Life Sciences·CIK 0001351051

Genesis Healthcare is a holding company whose subsidiaries collectively form one of the largest post-acute care providers in the United States. The company offers inpatient services, rehabilitation and respiratory therapy services, and a full range of administrative services to its affiliated operators through its administrative services subsidiaries. Genesis Healthcare also provides management services to third-party operators under contract through its management services subsidiary. The healthcare operating subsidiaries prioritize providing quality care, with skilled nursing facility subsidiaries forming the largest part of the consolidated business. These facilities are dedicated to treating high-acuity patients who need a high level of skilled nursing care and extensive rehabilitation therapy. Genesis Healthcare's services primarily address the medical and physical needs of elderly patients. These services are delivered by employees of its skilled nursing facilities, assisted/senior living communities, integrated and third-party rehabilitation therapy business, and other ancillary services. As of December 31, 2020, the company had three reportable operating segments: (1) inpatient services, which includes the operation of skilled nursing facilities and assisted/senior living facilities and represents the largest portion of the business; (2) rehabilitation therapy services, encompassing integrated and third-party rehabilitation and respiratory therapy services; and (3) all other services. For the year ended December 31, 2020, the inpatient services segment generated approximately 86% of the company's revenue, the rehabilitation therapy services segment generated approximately 10% of revenue, and all other services accounted for the remaining balance.

Genesis Healthcare (OTC:GENNQ) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 1 item for GENNQ at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-20, rated 8/10.

Recent high-impact activity:

  • Genesis Healthcare Settles Insider Dispute, Unsecured Creditors to Get $150M Cash

Financial Snapshot

Fiscal year ended December 31, 2020
Revenue
$3.91B
Net Income
-$58.96M
Diluted EPS
-$0.53
Op. Cash Flow
$315.73M
Free Cash Flow
$108.42M
Cash & Equivalents
$212.07M
Total Debt
$1.54B
Debt / Equity
-1.88×
Net Margin
-1.5%
Shares Outstanding
111.85M sh
Source: 10-K · filed 2021-03-16 · accession 0001558370-21-003091

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 19,253 shares in GENNQ as of the September 15, 2026 settlement, a 0.1% decrease from the prior period — about 1.0 days to cover at its recent average daily volume.

Short interest (bi-monthly positions)19,253 shares as of September 15, 2026
Change vs prior period▼ 0.1%
Days to cover1.00 at avg daily volume of 21,796

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

$0.000001 -0.00% today
52-week range · as of 2026-08-20 $0.000001 – $0.3001
Market cap
$122.82
Volume
249 (0.0× avg)
3-mo avg 9.9K
Live data · 2026-10-05 00:10 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed GENNQ - Latest Insights

GENNQ
Aug 19, 2026, 8:48 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $0.0002
Real-time Price: $0.000001 info
Change: Low Volume info
Market Cap: $122.818 info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets